{"id":"https://openalex.org/W2072625253","doi":"https://doi.org/10.1016/j.thromres.2014.11.009","title":"The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear","display_name":"The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear","publication_year":2014,"publication_date":"2014-11-18","ids":{"openalex":"https://openalex.org/W2072625253","doi":"https://doi.org/10.1016/j.thromres.2014.11.009","mag":"2072625253","pmid":"https://pubmed.ncbi.nlm.nih.gov/25527332","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4272760"},"language":"en","primary_location":{"id":"doi:10.1016/j.thromres.2014.11.009","doi":"https://doi.org/10.1016/j.thromres.2014.11.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.thromres.2014.11.009","pdf_url":null,"source":{"id":"https://openalex.org/S134546602","display_name":"Thrombosis Research","issn_l":"0049-3848","issn":["0049-3848","1879-2472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4272760","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074764154","display_name":"Cassandra P. Loren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Cassandra P. Loren","raw_affiliation_strings":["Department of Biomedical Engineering; Department of Cell & Developmental Biology. Electronic address: cassandraloren@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering; Department of Cell & Developmental Biology. Electronic address: cassandraloren@gmail.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027762259","display_name":"Joseph E. Aslan","orcid":"https://orcid.org/0000-0002-8873-0387","observed_orcids":["https://orcid.org/0000-0002-8873-0387"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph E. Aslan","raw_affiliation_strings":["Department of Biomedical Engineering; Department of Cell & Developmental Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering; Department of Cell & Developmental Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043378043","display_name":"Rachel A. Rigg","orcid":"https://orcid.org/0000-0003-4188-1935","observed_orcids":["https://orcid.org/0000-0003-4188-1935"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel A. Rigg","raw_affiliation_strings":["Department of Biomedical Engineering"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019469055","display_name":"Marie S. Nowak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie S. Nowak","raw_affiliation_strings":["Department of Biomedical Engineering; Department of Medical Physics, Universite des Sciences et Technologies de Lille, Villeneuve d'Ascq Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering; Department of Medical Physics, Universite des Sciences et Technologies de Lille, Villeneuve d'Ascq Cedex, France","institution_ids":["https://openalex.org/I2279609970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034988388","display_name":"Laura D. Healy","orcid":"https://orcid.org/0000-0002-3162-7100","observed_orcids":["https://orcid.org/0000-0002-3162-7100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura D. Healy","raw_affiliation_strings":["Department of Cell & Developmental Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell & Developmental Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036237322","display_name":"Andr\u00e1s Gruber","orcid":"https://orcid.org/0000-0001-6212-2247","observed_orcids":["https://orcid.org/0000-0001-6212-2247"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andr\u00e1s Gruber","raw_affiliation_strings":["Department of Biomedical Engineering; Division of Hematology & Medical Oncology, School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering; Division of Hematology & Medical Oncology, School of Medicine","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["Division of Hematology & Medical Oncology, School of Medicine; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Howard Hughes Medical Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology & Medical Oncology, School of Medicine; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Howard Hughes Medical Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I1344073410","https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050978437","display_name":"Owen J. T. McCarty","orcid":"https://orcid.org/0000-0001-9481-0124","observed_orcids":["https://orcid.org/0000-0001-9481-0124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen J.T. McCarty","raw_affiliation_strings":["Department of Biomedical Engineering; Department of Cell & Developmental Biology; Division of Hematology & Medical Oncology, School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering; Department of Cell & Developmental Biology; Division of Hematology & Medical Oncology, School of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5074764154"],"corresponding_institution_ids":[],"apc_list":{"value":4080,"currency":"USD","value_usd":4080},"apc_paid":null,"fwci":3.3104,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.92687148,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"135","issue":"1","first_page":"155","last_page":"160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":1.0},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.8259999752044678},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/itam-signaling","display_name":"ITAM signaling","score":0.9139999747276306},{"id":"https://openalex.org/keywords/platelet-spreading","display_name":"platelet spreading","score":0.5830000042915344},{"id":"https://openalex.org/keywords/platelet-granule-secretion","display_name":"platelet granule secretion","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hemorrhagic-diathesis","display_name":"bleeding tendency","score":0.8429999947547913},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.6100000143051147},{"id":"https://openalex.org/keywords/shear-stress","display_name":"shear stress","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.9269393682479858},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.6840336322784424},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5689648389816284},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5444662570953369},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5340335369110107},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5001907348632812},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.46864742040634155},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46086108684539795},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.43668702244758606},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.4344162940979004},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3257884383201599},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2997533679008484},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2755725383758545},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1084943413734436}],"mesh":[{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010718","descriptor_name":"Phosphatidylserines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014443","descriptor_name":"Tyrosine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015539","descriptor_name":"Platelet Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019007","descriptor_name":"P-Selectin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020816","descriptor_name":"Amino Acid Motifs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033081","descriptor_name":"Shear Strength","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D061625","descriptor_name":"Immunoreceptor Tyrosine-Based Activation Motif","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.thromres.2014.11.009","doi":"https://doi.org/10.1016/j.thromres.2014.11.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.thromres.2014.11.009","pdf_url":null,"source":{"id":"https://openalex.org/S134546602","display_name":"Thrombosis Research","issn_l":"0049-3848","issn":["0049-3848","1879-2472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis Research","raw_type":"journal-article"},{"id":"pmid:25527332","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25527332","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4272760","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4272760","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Thromb Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4272760","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4272760","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Thromb Res","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1999487110","display_name":"Oregon Clinical and Translational Research Institute","funder_award_id":"UL1TR000128","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2148971391","display_name":null,"funder_award_id":"UL1TR000128","funder_id":"https://openalex.org/F4320332578","funder_display_name":"Oregon Clinical and Translational Research Institute"},{"id":"https://openalex.org/G3256272670","display_name":null,"funder_award_id":"R01 HL101972","funder_id":"https://openalex.org/F4320306080","funder_display_name":"Foundation for the National Institutes of Health"},{"id":"https://openalex.org/G3806589214","display_name":null,"funder_award_id":"13POST13730003","funder_id":"https://openalex.org/F4320306230","funder_display_name":"American Heart Association"},{"id":"https://openalex.org/G6463605949","display_name":"Oregon Clinical and Translational Research Institute","funder_award_id":"UL1RR024140","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G8419720682","display_name":null,"funder_award_id":"13EIA12630000","funder_id":"https://openalex.org/F4320306230","funder_display_name":"American Heart Association"},{"id":"https://openalex.org/G9000913381","display_name":"Characterization of Coagulation Factor-platelet Interactions: Role of FXI","funder_award_id":"R01HL101972","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000919045","display_name":"OHSU Knight Cancer Institute","funder_award_id":"P30CA069533","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306080","display_name":"Foundation for the National Institutes of Health","ror":"https://ror.org/00k86s890"},{"id":"https://openalex.org/F4320306230","display_name":"American Heart Association","ror":"https://ror.org/013kjyp64"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332578","display_name":"Oregon Clinical and Translational Research Institute","ror":"https://ror.org/009avj582"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W64750453","https://openalex.org/W203138189","https://openalex.org/W1540012817","https://openalex.org/W1549514523","https://openalex.org/W1607745684","https://openalex.org/W1964138924","https://openalex.org/W1971749359","https://openalex.org/W1980834655","https://openalex.org/W1983007339","https://openalex.org/W1993675254","https://openalex.org/W1995564704","https://openalex.org/W2011448032","https://openalex.org/W2011960630","https://openalex.org/W2014839361","https://openalex.org/W2022177860","https://openalex.org/W2050564231","https://openalex.org/W2058272324","https://openalex.org/W2063055656","https://openalex.org/W2072793509","https://openalex.org/W2084333005","https://openalex.org/W2088096858","https://openalex.org/W2096500843","https://openalex.org/W2097946794","https://openalex.org/W2104983860","https://openalex.org/W2110648386","https://openalex.org/W2112504623","https://openalex.org/W2118971976","https://openalex.org/W2124196948","https://openalex.org/W2134566943","https://openalex.org/W2156480395","https://openalex.org/W2159372479","https://openalex.org/W2159989896","https://openalex.org/W2168217578","https://openalex.org/W2168411181","https://openalex.org/W2992837203","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2280289734","https://openalex.org/W3202895336","https://openalex.org/W1964138924","https://openalex.org/W4235434142","https://openalex.org/W4403206042","https://openalex.org/W2326650246","https://openalex.org/W2346884214","https://openalex.org/W2787823502","https://openalex.org/W4412954441","https://openalex.org/W2600728645"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}